Condition
Herbal Interaction
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
Early P 1 (1)
P 3 (1)
Trial Status
Completed2
Enrolling By Invitation1
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05739071Not ApplicableEnrolling By Invitation
JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer
NCT05846451Early Phase 1RecruitingPrimary
Evaluating a Potential Pharmacokinetic Kratom-oxycodone Interaction Concurrent With Clinical Endpoints
NCT05504447Not ApplicableUnknownPrimary
To Evaluate the Efficacy and Safety of "Rongyang Zhengyifang" Tea Bag With COVID-19 Variant Virus
NCT04702659CompletedPrimary
Chinese Medicine Zhengyi Prescription Tea Bag
NCT04974073Phase 3Completed
Development of PHY606 as Adjunct Therapy for Anemia Patients
Showing all 5 trials